Kwok Seng Loh Selected Research

Cisplatin (Platino)

10/2020	Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.
1/2018	Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwok Seng Loh Research Topics

Disease

20	Nasopharyngeal Carcinoma 12/2023 - 11/2002
10	Neoplasms (Cancer) 09/2022 - 12/2010
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2024 - 01/2018
3	COVID-19 12/2022 - 05/2021
2	Hemorrhage 01/2023 - 12/2022
1	Epstein-Barr Virus Infections 02/2024
1	Stroke (Strokes) 01/2023
1	Exanthema (Rash) 09/2022
1	Carcinogenesis 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021
1	Hypertension (High Blood Pressure) 10/2020
1	Virus Diseases (Viral Diseases) 09/2020
1	Hearing Loss (Hearing Impairment) 01/2018
1	Ototoxicity 01/2018
1	Goiter 08/2017
1	Squamous Cell Carcinoma of Head and Neck 12/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Infections 01/2016
1	Smooth Muscle Tumor 12/2010
1	Respiratory Sounds (Crackle) 12/2010
1	Neoplasm Metastasis (Metastasis) 12/2006
1	Carcinoma (Carcinomatosis) 01/2004

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2016
3	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2004
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
2	VaccinesIBA 12/2022 - 06/2022
2	Cetuximab (Erbitux)FDA Link 09/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2018
2	Keratins (Keratin)IBA 01/2018 - 01/2014
2	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2016 - 11/2002
1	AerosolsIBA 12/2022
1	Chimeric Antigen ReceptorsIBA 11/2022
1	AntibodiesIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	LigandsIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2021
1	Povidone-Iodine (Betadine)FDA LinkGeneric 05/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021
1	Sunitinib (Sutent)FDA Link 10/2020
1	Gemcitabine FDA Link 10/2020
1	Amyloid (Amyloid Fibrils)IBA 06/2019
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	poly ICLCIBA 01/2018
1	VimentinIBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2016
1	peptide AIBA 04/2016
1	Aldehyde DehydrogenaseIBA 08/2013

Therapy/Procedure

6	Therapeutics 09/2022 - 08/2013
4	Radiotherapy 12/2023 - 12/2006
3	Drug Therapy (Chemotherapy) 05/2021 - 08/2013
2	Chemoradiotherapy 01/2016 - 12/2006
1	Precision Medicine 02/2024
1	Stents 01/2023
1	Ligation 12/2022
1	Personal Protective Equipment 12/2022
1	Chemoprevention 05/2021
1	Immunotherapy 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Thyroidectomy 08/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2016
1	Subcutaneous Injections 08/2013
1	Transplantation 12/2010